“SAFETY, EFFICACY, AND EFFECTIVENESS OF BRENTUXIMAB VEDOTIN IN THE TREATMENT OF RELAPSED OR REFRACTORY CD30+ HODGKIN LYMPHOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION: A SYSTEMATIC REVIEW”. REMUNOM 2, no. 02 (February 19, 2026): 1–23. Accessed February 25, 2026. https://remunom.ojsbr.com/multidisciplinar/article/view/5503.